Israel Biotech Fund
Venture capitalRehovot · Seed–Series A · 4 people tracked
Also known as I.B.F. MANAGEMENT LTD.
Investment thesis
Israel Biotech Fund invests in biotechnology and pharmaceutical companies based in or connected to Israel, operating across the development and growth stages. The fund focuses on building Israeli biotech enterprises with the objective of delivering capital appreciation to investors.
Source: firm website, verified Aug 25, 2026.
Team · 4 people
from public directories
What they invest in
from 14 of 17 portfolio companiesBiotech ×14Healthtech ×7Medical Devices ×4AI & Machine Learning ×3Deep Tech ×1Digital Health ×1Longevity ×1
HQs:United States×5Israel×2
Investments · 17 tracked
founders shown can be your intro pathBy year:2023 · 12017 · 22015 · 36 dated
Champions Oncology offers a KRAS-focused preclinical platform built on patient-derived xenograft (PDX) models screened with the pan-RAS(ON) inhibitor daraxonrasib, combining in vivo pharmacology with multi-omic characterization to study drug response and resistance.
AI & Machine LearningBiotechHealthtechHackensack, US
Ronnie Morris(Executive Officer, Director)James McGorry(Executive Officer)David Miller(Chief Financial Officer)Joel Ackerman(Executive Officer, Director)David Sidransky, M.D.(Director)Ronnie Morris, M.D.(Executive Officer, Director)
Board seatDavid Sidransky· per SEC Form D · $14M raise · filed Mar 2015
Co-investorsBattery VenturesNew Enterprise Associates (NEA)
Galmed Pharma is a drug development company working on metabolic and inflammatory therapeutics, focused on medicines for inflammatory diseases.
BiotechTel Aviv
Ran Oren(Director)Tali Gorfine(Executive Officer)Carol Brosgart(Director)Yohai Stenzler(Executive Officer)Liat Hayardeny(Executive Officer)Shmuel Nir(Director)
Board seatDavid Sidransky· per SEC Form D · $350K raise · filed Aug 2017
MediWound is a biotechnology company developing enzymatic treatments that selectively remove eschar tissue while preserving healthy tissue for burns and chronic wounds.
BiotechHealthtechMedical DevicesYavne
Boaz Gur-Lavie(Chief Financial Officer)Sharon Malka(Director)Ety Klinger(Executive Officer, Director)inTzvi Palash(Executive Officer)Assaf Segal(Director)Sharon Kochan(Director)
Co-investorsClal Biotechnology IndustriesDeep InsightGandyr InvestmentsNew Era Capital Partners
AION Labs is a venture studio that creates AI, technology, and science startups focused on pharmaceutical R&D, using a co-development model that gives startups access to pharma expertise, validation opportunities, and pre-seed funding.
AI & Machine LearningBiotechDeep Tech
Co-investorsAmiti Ventures
Vensica is a clinical-stage medical company developing ViXe, a needle-free treatment for overactive bladder that combines the neurotoxin Xeomin with Vibe, an ultrasound-based drug delivery device that microinjects medication into the bladder wall.
BiotechHealthtechMedical Devices
Avner Geva(CEO, Co-founder)Avi Eftel(CTO, Co-founder)Roger R. Dmochowski(CMO)Ken Berlin(Executive Chairman)
Co-investorsTrendlines Group
BiotechMonmouth Junction, US
Igor Gitelman(Director)Andres Gutierrez(Executive Officer)Kenneth Berlin(Executive Officer, Director)Roni Appel(Director)Thomas Moore(Executive Officer, Director)John Rothman(Executive Officer)
Board seatDavid SidranskyYuval Cabilly· per SEC Form D · $433.8K raise · filed Nov 2023
Orgenesis operates the POCare Platform for developing, scaling, and commercializing advanced cell and gene therapies delivered at the point of care.
BiotechHealthtechMedical DevicesGermantown, US
Neil Reithinger(Executive Officer)Vered Caplan(Executive Officer, Director)Ferber Ferber(Executive Officer)Joseph Tenne(Executive Officer)Sarah Ferber(Executive Officer)Guy Yachin(Director)
Board seatDavid Sidransky· per SEC Form D · $10M raise · filed Dec 2015
BiotechSan Diego, US
Jamie Sulley(Executive Officer, Director)Joanne Barsa(Executive Officer)David Sidrandky(Director)
BoardFred Knoll(Director)Patrick Ostronick(Director)
Board seatDavid Sidransky· per SEC Form D · $800K raise · filed Sep 2015
4C Biomed develops immuno-oncology therapies using a patient-derived discovery platform that identifies novel immune targets from autologous cancer and immune cell systems.
BiotechHealthtech
Ayala Pharma is associated with pharmaceutical drug candidates including AL102, AL101, and BST-236; the page states that AL102 and AL101 were acquired by Immunome, Inc. in Q1 2024.
Biotech
Co-investorsaMoon
Co-investorsDeep Insight
Gamida Cell develops allogeneic cell therapy products using its proprietary nicotinamide (NAM) technology to enhance and expand cells for treating patients with hematologic and non-hematologic conditions.
BiotechHealthtechLongevity
Nectin is a biotech developing a pipeline of targeted immunotherapies, including immuno-oncology antibodies and antibody-drug conjugates (ADCs).
BiotechMedical Devices
Co-investorsPeregrine Ventures
Ukko develops immuno-therapeutics for life-threatening food allergies using a computational protein design platform.
AI & Machine LearningBiotechDigital HealthMountain View, US
Anat Binur(Executive Officer, Director)Yanay Ofran(Director)Judith Weiss Paltiel(PhD, VP Development)
BoardScott Brady(Director)Samir Kaul(Director)in
Co-investorsKhosla VenturesSanara CapitalWestern Technology InvestmentFall Line CapitalLeaps by BayerPeakBridge VC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
IPOs and acquisitions across the tracked portfolioChampions OncologyNASDAQ: CSBRGalmed PharmaceuticalsNASDAQ: GLMDMediwoundNASDAQ: MDWD
Frequently asked questions
- How many investments has Israel Biotech Fund made?
- Israel Biotech Fund has 13 tracked investments.
- What stage does Israel Biotech Fund invest at?
- Israel Biotech Fund invests at the Seed, Series A stages.
- What sectors does Israel Biotech Fund focus on?
- Israel Biotech Fund focuses on Biotech, Digital Health, Medical Devices.
- Where is Israel Biotech Fund located?
- Israel Biotech Fund is headquartered in Rehovot, IL.
- Who does Israel Biotech Fund co-invest with?
- Israel Biotech Fund most often shares deals with aMoon, Deep Insight, DCVC (Data Collective), among 26 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.